Developmental risks can arise from living in a city.

Published Date: 27 Dec 2023

Over 60% of the world's population is predicted to reside in cities by the year 2030. The wide range of urban exposures that young children experience, from noise and air pollution to crowding, is highlighted by new research.

Read Full News

Latest News

US FDA Approves Vertex's Gene Therapy for Sickle Cell Disease in Children as Young as Two

The U.S. Food and Drug Administration approved expanded use of Vertex Pharmaceuticals' gene therapy in ⁠children as young as two with inherited blood disorders, including...

US FDA Declines Lantheus’ Tumor Imaging Kit Over Third-party Manufacturing Issues

The U.S. Food and Drug Administration declined to approve Lantheus Holdings’ diagnostic ⁠imaging kit for types of cancer tumors, citing unresolved issues at a third-party...

Habit Score Tied to Improved Inhaled Drug Adherence in CF

Habit formation is a key modifiable factor for adherence to inhaled therapy in adults with cystic fibrosis; age, socioeconomic status, neurodivergence and complex regimens also influence adherence.

Ginkgo biloba Adds an Edge in Pediatric Enuresis

Ginkgo biloba extract, alone or in combination with desmopressin, is safe and effective for treating monosymptomatic nocturnal enuresis in children, a trial shows.

Counsel Families on Prevention of Drowning

American Academy of Pediatrics issued a policy statement updating guidance on how to counsel patients and families about preventing drowning.

Digital Addiction: Can an AI App Detect Warning Signs?

Researchers develop an AI tool that assesses smartphone interactions and flags patterns associated with vulnerability to compulsive digital behaviors.

Todays Updates

Enhancing Comprehensive Biomarker Testing and Biomarker-Directed Treatment Selection

Enhancing Comprehensive Biomarker Testing and Biomarker-Directed Treatment Selection

Advancing Care in ES-SCLC: Personalized Strategies, New Therapies, and Real-World Insights

Advancing Care in ES-SCLC: Personalized Strategies, New Therapies, and Real-World Insights

Adjuvant Combination for Kidney Cancer Gets FDA's Blessing

Belzutifan and pembrolizumab together reduced the risk of disease recurrence or death

FDA Approves Prostate Cancer Combo That Warranted Advisory Meeting

Capivasertib plus abiraterone combination lands indication for PTEN-deficient tumors

Talquetamab Regimens Boost Survival in Multiple Myeloma

"Combinations represent additional options for early-line treatment," researcher says

In High-Risk B-Cell ALL, Swapping Out Chemo for Blinatumomab Improves Outcomes

The bispecific T-cell engager also reduced toxicity in newly diagnosed kids

Timely 'Nudges' Can Help Encourage More End-of-Life Conversations in Cancer

A combination of clinician and patient prompts worked best, but talks remained infrequent

Todays Updates

Enhancing Comprehensive Biomarker Testing and Biomarker-Directed Treatment Selection

Enhancing Comprehensive Biomarker Testing and Biomarker-Directed Treatment Selection

Advancing Care in ES-SCLC: Personalized Strategies, New Therapies, and Real-World Insights

Advancing Care in ES-SCLC: Personalized Strategies, New Therapies, and Real-World Insights

Adjuvant Combination for Kidney Cancer Gets FDA's Blessing

Belzutifan and pembrolizumab together reduced the risk of disease recurrence or death

FDA Approves Prostate Cancer Combo That Warranted Advisory Meeting

Capivasertib plus abiraterone combination lands indication for PTEN-deficient tumors

Talquetamab Regimens Boost Survival in Multiple Myeloma

"Combinations represent additional options for early-line treatment," researcher says

In High-Risk B-Cell ALL, Swapping Out Chemo for Blinatumomab Improves Outcomes

The bispecific T-cell engager also reduced toxicity in newly diagnosed kids

Timely 'Nudges' Can Help Encourage More End-of-Life Conversations in Cancer

A combination of clinician and patient prompts worked best, but talks remained infrequent

Latest News

The U.S. Food and Drug Administration approved expanded use of Vertex Pharmaceuticals' gene therapy in ⁠children as young as two with inherited blood disorders, including...

The U.S. Food and Drug Administration declined to approve Lantheus Holdings’ diagnostic ⁠imaging kit for types of cancer tumors, citing unresolved issues at a third-party...

Habit formation is a key modifiable factor for adherence to inhaled therapy in adults with cystic fibrosis; age, socioeconomic status, neurodivergence and complex regimens also influence adherence.

Ginkgo biloba extract, alone or in combination with desmopressin, is safe and effective for treating monosymptomatic nocturnal enuresis in children, a trial shows.

American Academy of Pediatrics issued a policy statement updating guidance on how to counsel patients and families about preventing drowning.

Researchers develop an AI tool that assesses smartphone interactions and flags patterns associated with vulnerability to compulsive digital behaviors.

News All Time

Personalizing the Care of Food Allergy in an Era of Novel Treatment Options

Personalizing the Care of Food Allergy in an Era of Novel Treatment Options
HTTP error: 503HTTP error: 503

PAS: Pediatric Academic Societies

RFK Jr. Defends Trump's Sanity; Poison in Baby Food; $600,000 Rehab on a Giant Yacht

Health news and commentary gathered by MedPage Today staff

Fact-Check: RFK Jr. Says U.S. Is Handling Measles Better Than the Rest of the World

The U.S. is getting worse, not better, at protecting people against the spread of measles

988 Launch Tied to Drop in Youth Suicides

Lifeline "appears to be working where it matters most," researcher says
HTTP error: 503HTTP error: 503HTTP error: 503

Vaccines, Budget Cuts, Affordability: Takeaways From RFK Jr.'s Gauntlet of Hearings

Kennedy acknowledged some HHS cuts are "painful"
HTTP error: 503HTTP error: 503

New Maintenance Option Approved for Asthma

Breztri becomes the first single-inhaler triple therapy for patients as young as 12 years
HTTP error: 503

Chocolate Product Recall; Trump Admin Fights Vaccine Ruling; Measles in Travelers

Health news and commentary gathered by MedPage Today staff

Recommended News For You

Recommended Articles For You

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Researchers can now forecast how prostate cancer bone metastases will react to radium-223 treatment.

2.

Cardiopulmonary fitness is key for helping breast cancer patients manage post-diagnosis symptoms, say researchers

3.

In R/R Follicular Lymphoma, Tisa-Cel Produces Long-Lasting Responses.

4.

In MDS at Lower Risk, Novel Therapy Diminished Transfusion Dependency.

5.

WHO launches plan for free child cancer medicines

1.

Innovative Directions in Hematology Across Clinical Settings

2.

Transformative Approaches in Hematology for Healthcare Excellence

3.

How HLH is Revolutionizing Healthcare

4.

Essential Perspectives in Hematology and Patient Outcomes

5.

Neutrophil Profiling and AI Rewrites Cancer Diagnosis

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

2.

Navigating the Complexities of Ph Negative ALL - Part III

3.

Role of Nimotuzumab in Management of Nasopharyngeal Cancer

4.

Navigating the Complexities of Ph Negative ALL - Part X

5.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot